Taking peritoneal dialysis beyond the year 2000

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 3, 1999, Pages

  Gokal, Ram ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adequacy; Early start; Icodextrin; Patient survival; Peritoneal dialysis solutions; Prescription

Indexed keywords

DIALYSIS FLUID; ICODEXTRIN;

AUTOMATION; BIOCOMPATIBILITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; HEALTH ECONOMICS; HEMODIALYSIS; HUMAN; LIFESTYLE; MEMBRANE PERMEABILITY; NUTRITION; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT MONITORING; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 0033408337     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901903s07     Document Type: Conference Paper

References (67)

1. Nolph KD. Continuous ambulatory peritoneal dialysis. Am J Nephrol 1981; 1:1-10.
2. Anonymous. Chronic ambulatory peritoneal dialysis. Br Med J 1979; 2:229-31.
3. Jacobs C, Broyer M, Brunner FP, Brynger H, Donckerwolke RA, Kramer P, et al. Combined report on regular dialysis and transplantation in Europe, XI, 1980. Proc EDTA 1981; 18:38-76.
4. Shaldon S, Koch KM, Quellhorst E, Lonneman G, Dinarello C. CAPD is a second class treatment. Contrib Nephrol 1985; 44:163-5.
5. Nolph KD. Why are reported relative mortality risks for CAPD and HD so variable? Perit Dial Int 1996; 16:15-18.
6. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:177-83.
7. Piccoli G, Salomone M, Quarello F, Piccoli GB, Verzetti G, Ramello A, et al. Regional Registry of Dialysis and Transplantation of Piedmont, Italy. Thirteen years of experience. Nephrol Dial Transplant 1995; 10:444-7.
8. Fenton S, Desmeules M, Copleston P, Arbus G, Froment D, Jeffery J, et al. Renal replacement therapy in Canada: a report from the Canadian Organ Replacement Register. Am J Kidney Dis 1995; 25:134-50.
9. Fenton SSA, Schaubel DE, Desmeules M, Morrison SI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30:334-42.
10. Disney APS, ed. Australia and New Zealand Dialysis and Transplant Registry Report 1997. Adelaide, Australia, 1998.
11. Data presented at the European Renal Association - European Dialysis and Transplant Association Congress, June, 1998.
12. Maiorca R, Cancarini GC. Outcome of peritoneal dialysis: comparative studies. In: Gokal R, Nolph KD, eds. Textbook of peritoneal dialysis. Dordrecht: Kluwer Academic Publishers, 1994:699-734.
13. Gokal R. CAPD overview. Perit Dial Int. 1996; 16(Suppl 1):S13-18.
14. Davies S, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54:2207-17.
15. Gokal R, Oreopoulos DG. Is long-term CAPD possible? Perit Dial Int 1996; 16:553-5.
16. Maiorca R, Cancarini GC, Zubani R, Camerini C, Manili L, Brunori G, et al. CAPD viability: a long-term comparison with hemodialysis. Perit Dial Int 1996; 16:276-87.
17. Maiorca R, Vonesh E, Cavalli PL, De Vecchi A, Giangrande A, La Greca G, et al. A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11:118-27.
18. Rotellar C, Black J, Winchester JF, Rakowski TA, Mosher WF, Mazzoni MJ, et al. Ten years experience with CAPD. Am J Kidney Dis 1991; 17:158-64.
19. Lupo A, Tarchini R, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, et al. Long-term outcome in CAPD: a long-term survey by the Italian Co-operative Peritoneal Dialysis Study Group. Am J Kidney Dis 1994; 24:826-37.
20. Kawaguchi Y, Hasegawa T, Nakayama M, Kubo H, Shigematsu T. Issues affecting the longevity of continuous peritoneal dialysis therapy. Kidney Int 1997; 52(Suppl 62):S105-7.
21. Popovich RP, Moncrief JW, Decherd DF, Bomar JB, Pyle WK. The definition of a novel portable/wearable equilibrium dialysis technique (Abstract). ASAIO Trans 1976; 5:64.
22. Teehan BP, Schleifer CR, Sigler MH. A quantitative approach to the CAPD prescription. Perit Dial Bull 1985; 5:153-6.
23. United States Renal Data Systems. USRDS 1992 annual data report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1992.
24. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 1997; 30(Suppl 2):S67-136.
25. The Renal Association and Royal College of Physicians of London. Treatment of adult patients with renal failure - recommended standards and audit measures. London: Royal College of Physicians, 1997.
26. Blake P, Burkart J, Churchill D. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16:448-56.
27. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7:198-207.
28. Gokal R, Harty J. Are there limits for CAPD? Adequacy and nutritional considerations. Perit Dial Int 1996; 16:437-41.
29. Twardowski ZJ, Nolph KD. Is peritoneal dialysis feasible once a large muscular patient becomes anuric? Perit Dial Int 1996; 16:20-3.
30. Canadian Organ Replacement Register. Annual report 1998. Volume 1: Dialysis and renal transplantation. Ottawa: Canadian Institute for Health Information, June 1998.
31. United States Renal Data System. USRDS 1997 annual data report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997.
32. Health Care Financing Administration. Highlights from the 1998 ESRD Core Indicators Project for Peritoneal Dialysis Patients. Baltimore, MD: Department of Health Care and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality, 1998.
33. Rocco M, Frankenfield D, Frederick P, Flanigan M, Prowant B, Bailie G, for the HCFA Core Indicators Work Group. Trends in clinical indicators of care for adult peritoneal dialysis patients in the US from 1995 to 1997 (Abstract). J Am Soc Nephrol 1998; 9:301A.
34. Health Care Financing Administration. 1997 Annual Report, ESRD Core Indicators Project. Baltimore, MD: Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality, December 1997.
35. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 1998; 9:1285-93.
36. Heaf J. CAPD adequacy and dialysis morbidity: detrimental effect of a high peritoneal equilibration rate. Ren Fail 1995; 17:575-87.
37. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival independent of residual renal function. Nephrol Dial Transplant 1998; 13:962-8.
38. Tattersal J, Greenwood R, Farrington K. Urea kinetics and when to commence dialysis. Am J Nephrol 1995; 15:283-9.
39. Obrador GT, Ruthazer R, Arora P, Pereira BJG, Levey AS. What is the level of GFR in the US ESRD population (Abstract)? J Am Soc Nephrol 1998; 9:220A.
40. Jansen MAM, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT, and the NECOSAD Study Group. Residual renal function and nutritional status at the start of chronic dialysis treatment (Abstract). J Am Soc Nephrol 1998; 9:212A.
41. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995; 6:1386-91
42. Kopple JD, Berg R, Houser H, Steinman TI, Techan P, for the Modification of Diet in Renal Disease (MDRD) Study Group. Nutritional status of patients with different levels of chronic renal insufficiency. Kidney Int 1989; 36(Suppl 27):S184-94.
43. McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN, for the CANUSA Study Group. How much peritoneal dialysis is required for maintaining a good nutritional state? Kidney Int 1996; 50(Suppl 56):S56-61.
44. Churchill DN. An evidence based approach to earlier initiation of dialysis. Am J Kidney Dis 1997; 30: 899-906.
45. Gamba G, Mejia JL, Saldivar S, Pena JC, Correa-Rotter R. Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron 1993; 65:23-7.
46. Iseki K, Uehara H, Nishime K, Tokuyama K, Yoshihara K, Kinjo K, et al. Impact of the initial levels of laboratory variables on the survival in chronic dialysis patients. Am J Kidney Dis 1996; 28:541-8.
47. Barrett BJ, Parfrey PS, Morgan J. Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 1997; 29:214-22.
48. Mehrotra R, Saran R, Moore HL, Prowant BF, Khanna R, Twardowski ZJ, et al. Toward targets for initiation of chronic dialysis. Perit Dial Int 1997; 17:497-508.
49. Mehrotra R, Nolph KD, Gotch F. Early initiation of chronic dialysis: role of incremental dialysis. Perit Dial Int 1997; 17:426-30.
50. Bleyer AJ, Burkart JM, Russell GB, Adams PL. Dialysis modality and delayed graft function after cadaveric renal transplantation. J Am Soc Nephrol 1999; 10:154-9.
51. Nicholson ML, Wheatley TJ, Horsburgh T, Edwards CM, Veitch PS, Bell PR. The relative influence of delayed graft function and acute rejection on renal transplant survival. Transpl Int 1996; 9:415-19.
52. Van Biesen W, De Vogeleere P, Vijt D, Vanholder R, Lameire N. Integrated care can improve long-term survival of ESRD patients (Abstract). Perit Dial Int 1998; 18(Suppl 2):S13.
53. Nissenson A, Prichard SS, Cheng IPK, Gokal R, Kubota M, Maiorca R, et al. Non-medical factors that impact on ESRD modality selection. Kidney Int 1993; 43(Suppl 40):S120-7.
54. Slingeneyer A, De Vecchi A, Faller B, Gokal R, Hellström H, Joffe P, et al. Multicenter study on patient referral to dialysis (Abstract). J Am Soc Nephrol 1998; 9:226A.
55. Lameire N, Van Biesen W, Dombros N, Dratwa M, Faller B, Gahl G, et al. The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality. Perit Dial Int 1997; 17(Suppl 2):S161-6.
56. Coles G, Williams JD. What is the place of peritoneal dialysis in the integrated treatment of renal failure? Kidney Int 1998; 54:2234-40.
57. Coles GA. Are solutions presently used biocompatible? Perit Dial Int 1995; 15(7) (Suppl):S109-14.
58. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival independent of residual renal function. Nephrol Dial Transplant 1998; 13:962-8.
59. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
60. Topley N, Coles GA, Williams JD. Biocompatibility studies on peritoneal cells. Perit Dial Int 1994; 14(Suppl 3):21-8.
61. Yamada K, Miyahara Y, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, et al. Immunohistochemical study of human advanced glycosylation end products (AGE) in chronic renal failure. Clin Nephrol 1994; 42:354-61.
62. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51:182-6.
63. Rippe B, Simonsen O, Wieslander A, Landgren C. Clinical and physiological effects of a new, less toxic and less acidic solution for peritoneal dialysis. Perit Dial Int 1997; 17:27-34.
64. Wieslander AP, Andrén AHG, Nilsson-Thorell C, Muscalu N, Kjellstrand PTT, Rippe B. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 1995; 15:348-52.
65. Hendriks PMEM, Ho-dac-Pannekeet MM, van Gulik TM, Struijk DG, Phoa SSKS, Sie LH, et al. Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 1997; 17:136-43.
66. Ho-dac-Pannekeet MM, Struijk DG, Krediet RT. Improvement of transcellular water transport by treatment with glucose free dialysate in patients with ultrafiltration failure (Abstract). Nephrol Dial Transplant 1996; 11:255.
67. Pederson FB. Lactate versus bicarbonate based peritoneal dialysis solutions. Perit Dial Int 1995; 15(7)